"Adagene" example sentences

"Adagene" Example Sentences

1. Adagene is a biopharmaceutical company focused on the development of innovative therapies.
2. The company's technology platform is based on its proprietary gene expression and protein engineering capabilities.
3. Adagene has a strong pipeline of therapeutic candidates in oncology, immunology and metabolic diseases.
4. Adagene's mission is to develop breakthrough therapies that will improve the lives of patients with unmet medical needs.
5. Adagene's lead product is a novel monoclonal antibody targeting the PD-1/PD-L1 pathway.
6. Adagene has established strategic collaborations with leading biopharmaceutical companies.
7. The company is committed to developing innovative therapies that will benefit patients worldwide.
8. Adagene is focused on developing therapies that target immune-mediated diseases.
9. Adagene is actively engaged in research and development of novel therapeutic approaches.
10. Adagene is dedicated to advancing the science of gene therapy and protein engineering.
11. Adagene has a portfolio of novel therapeutic candidates in oncology, immunology and metabolic diseases.
12. Adagene is developing a pipeline of innovative therapies that target a range of diseases.
13. Adagene is leveraging its proprietary gene expression and protein engineering technology platform to develop novel therapies.
14. Adagene is committed to delivering innovative therapies to patients with unmet medical needs.
15. Adagene is focused on developing therapies that target the underlying causes of disease.
16. Adagene is investing in research and development of novel therapeutic approaches.
17. Adagene is exploring new ways to treat a variety of diseases through its gene expression and protein engineering technology.
18. Adagene is dedicated to advancing the science of gene therapy and protein engineering for the benefit of patients.
19. Adagene is committed to developing therapies that will improve the lives of patients with unmet medical needs.
20. Adagene is developing a pipeline of novel therapeutic candidates in oncology, immunology and metabolic diseases.